Hepatology
Hepatology
03-08-2018 | HBV | News | Article
HCC risk remains even after achieving positive HBV outcomes
Two meta-analyses published in the Journal of Viral Hepatitis confirm that patients with hepatitis B virus infection remain at risk for hepatocellular carcinoma even after achieving positive virologic outcomes, and identify factors associated with the risk.
03-08-2018 | HBV | News | Article
Global HBV prevalence estimated at 3.9%
More than 290 million people, or 3.9% of the global population, are infected with hepatitis B virus, and while efforts to combat infection are improving, greater access to diagnosis and treatment is needed to meet global targets, report The Polaris Observatory Collaborators.
05-07-2018 | Oncology | News | Article
Advanced HCC survival boost with cabozantinib
Patients with previously treated advanced hepatocellular carcinoma may derive a survival advantage from treatment with the multikinase inhibitor cabozantinib, CELESTIAL trial results indicate.
03-05-2018 | HBV | News | Article
End of treatment HBsAg levels may predict HBV relapse
Hepatitis B surface antigen levels at the end of treatment or prophylaxis with nucleos(t)ide analog inhibitors could be a useful indicator of hepatitis B virus relapse, suggest two Taiwanese studies.
22-12-2017 | HBV | News | Article
FIB-4 index identifies chronic HBV patients with lowest HCC risk
The noninvasive fibrosis-4 index can further refine the existing favorable clinical profile for hepatocellular carcinoma risk in noncirrhotic patients with chronic hepatitis B virus infection and help identify those with the lowest risk, say researchers.
29-09-2017 | HBV | News | Article
Novel indices to diagnose fibrosis in chronic HBV patients developed
Two research groups have developed noninvasive indices to detect significant fibrosis in treatment-naïve patients with chronic hepatitis B virus infection, one using serum levels of Golgi protein 73 and liver stiffness, and the other based on the ratio of gamma-glutamyl transpeptidase to albumin.
27-07-2017 | HBV | News | Article
Temporal liver cancer trends in HBV-endemic population mapped
A South Korean population-based study shows an increase in liver cancer burden over a 14-year period, while another analysis in the same population shows an improvement in the survival of patients with hepatocellular cancer in the past decade.
Image Credits
World map, Folder_Binders in background/© Bacho Foto / Fotolia, World map/© mumindurmaz35 / Fotolia